Less than 18 years of age;
Pregnancy;
Chronic use of vitamin K antagonists or direct thrombin inhibitors, or oral Xa-factor antagonists;
Hypersensitivity to antiplatelet and/or anticoagulant drugs;
Active bleeding or high bleeding risk (severe liver failure, active peptic ulcer, creatinine clearance < 30 mL/min, platelets count < 100.000 mm3);
Uncontrolled systemic hypertension;
Cardiogenic shock;
Previous myocardial revascularization surgery with = 1 internal mammary or radial artery graft;
Documented chronic peripheral arterial disease preventing the use of the femoral technique;
Severe concomitant disease with life expectancy below 12 months;
Participation in drug or devices investigative clinical trials in the last 30 days;
Medical, geographic or social conditions impairing the participation in the study or inability to understand and sign the informed consent term.

NCT02831166_exc_T1
Value
Less than 18 years
NCT02831166_exc_T2
Person
age
NCT02831166_exc_T3
Condition
Pregnancy
NCT02831166_exc_T4
Drug
vitamin K antagonists
NCT02831166_exc_T5
Multiplier
Chronic
NCT02831166_exc_T6
Drug
direct thrombin inhibitors
NCT02831166_exc_T7
Drug
oral Xa-factor antagonists
NCT02831166_exc_T8
Scope
vitamin K antagonists or direct thrombin inhibitors, or oral Xa-factor antagonists
NCT02831166_exc_T9
Condition
Hypersensitivity
NCT02831166_exc_T10
Drug
iplatelet an gs;
A
NCT02831166_exc_T11
Drug
anticoagulant drugs
NCT02831166_exc_T12
Scope
antiplatelet and/or anticoagulant drugs
NCT02831166_exc_T13
Condition
high bleeding risk
NCT02831166_exc_T14
Condition
bleeding
NCT02831166_exc_T15
Qualifier
Active
NCT02831166_exc_T16
Condition
liver failure
NCT02831166_exc_T17
Qualifier
severe
NCT02831166_exc_T18
Qualifier
active
NCT02831166_exc_T19
Condition
peptic ulcer
NCT02831166_exc_T20
Measurement
creatinine clearance
NCT02831166_exc_T21
Value
< 30 mL/min
NCT02831166_exc_T22
Measurement
platelets count
NCT02831166_exc_T23
Value
< 100.000 mm3
NCT02831166_exc_T24
Qualifier
Uncontrolled
NCT02831166_exc_T25
Condition
systemic hypertension
NCT02831166_exc_T26
Condition
Cardiogenic shock
NCT02831166_exc_T27
Procedure
myocardial revascularization surgery
NCT02831166_exc_T28
Temporal
Previous
NCT02831166_exc_T29
Device
l mammary or rad Docum
NCT02831166_exc_T30
Device
radial artery graft
NCT02831166_exc_T31
Multiplier
= 1
NCT02831166_exc_T32
Scope
internal mammary or radial artery graft
NCT02831166_exc_T33
Qualifier
chronic
NCT02831166_exc_T34
Condition
peripheral arterial disease
NCT02831166_exc_T35
Procedure
femoral technique
NCT02831166_exc_T36
Negation
preventing
NCT02831166_exc_T37
Qualifier
Severe
NCT02831166_exc_T38
Temporal
concomitant
NCT02831166_exc_T39
Condition
disease
NCT02831166_exc_T40
Observation
life expectancy
NCT02831166_exc_T41
Value
below 12 months